SLC
MRK icon

Second Line Capital’s Merck MRK Stock Holding History

Second Line Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$716K Sell
5,534
-340
-6% -$39.8K 0.13% 64
2026
Q1 		$641K Buy
5,874
+224
+4% +$25.9K 0.12% 76
2025
Q4 		$600K Sell
5,650
-99
-2% -$9.29K 0.12% 67
2025
Q3 		$487K Sell
5,749
-329
-5% -$27.1K 0.1% 77
2025
Q2 		$486K Buy
6,078
+715
+13% +$56.8K 0.11% 68
2025
Q1 		$486K Buy
5,363
+297
+6% +$27.7K 0.13% 68
2024
Q4 		$508K Sell
5,066
-271
-5% -$27.9K 0.14% 58
2024
Q3 		$610K Buy
5,337
+703
+15% +$83.5K 0.17% 61
2024
Q2 		$577K Buy
4,634
+772
+20% +$99.4K 0.18% 58
2024
Q1 		$512K Buy
3,862
+1,342
+53% +$165K 0.17% 59
2023
Q4 		$277K Buy
+2,520
New +$262K 0.11% 82

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Second Line Capital's MRK Position: Q2 2026 in Review

Second Line Capital reduced its Merck (MRK) stake by 5.8% in Q2 2026, selling an estimated $39.8K and leaving 5,534 shares worth $716K. The position accounts for 0.13% of the portfolio, ranked #64.

Second Line Capital first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Second Line Capital held 5,534 shares of Merck worth $716K as of Q2 2026.
  • Second Line Capital sold 340 Merck shares in Q2 2026, an estimated $39.8K.
  • Merck made up 0.13% of Second Line Capital's portfolio in Q2 2026, its #64 holding.
  • Second Line Capital first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.